Cardlytics CDLX Institutional Ownership

Cardlytics, Inc. (NASDAQ:CDLX) appears in 43 institutional 13F filings for the quarter ending June 2026.

• These investors held 30.2% of outstanding shares in June 2026, down from 32.0% in March 2026.
• They increased total shares held in Cardlytics by 234.92% from last quarter, and the number of investors in CDLX decreased 51.14% annually.
• During the quarter, 42 of these 43 funds increased positions in CDLX, 1 reduced exposure, and 0 held steady.
• In total, institutional investors held 1.74Mn shares in Cardlytics as of June 2026, up by 1.22Mn shares quarter on quarter, and down 681.67K shares year over year.
• As of June 30, 2026, CAS Investment Partners, LLC held the largest stake in Cardlytics with 470.99K shares, accounting for 8.18% of total shares outstanding.
• The most significant purchases of CDLX for the quarter ending June 2026 came from VANGUARD CAPITAL MANAGEMENT LLC (218.61K), 683 Capital Management, LLC (200.0K), KPS Global Asset Management UK Ltd (121.88K), WORLDLY PARTNERS MANAGEMENT, LLC (115.8K), BlackRock, Inc. (84.65K).
• Top sellers of CDLX stock for the quarter ending June 2026 included CAS Investment Partners, LLC (48.82K).
• Per Business Quant data, the top 10 holders of Cardlytics for the quarter ending June 2026 are CAS Investment Partners, LLC (470.99K), VANGUARD CAPITAL MANAGEMENT LLC (218.61K), 683 Capital Management, LLC (200.0K), KPS Global Asset Management UK Ltd (121.88K), WORLDLY PARTNERS MANAGEMENT, LLC (115.8K), BlackRock, Inc. (84.65K), RBF Capital, LLC (80.01K), GEODE CAPITAL MANAGEMENT, LLC (58.62K), Quinn Opportunity Partners LLC (46.24K), JANE STREET GROUP, LLC (39.54K).